
Sign up to save your podcasts
Or


Dr. Andrew Anzalone, head of the Prime Editing Platform and scientific co-founder at Prime Medicine, is the winner of the PEGS Boston 2023 Young Scientist Keynote. He was invited to sit down with Brandon DeKosky, assistant professor of chemical engineering at MIT, to discuss prime editing and its precision in treating inherited genetic mutations. Anzalone outlines the next generation tool’s advantages over traditional CRISPR methods and the mechanism creating fewer gene editing errors. He also discusses his clinical training and background, the ongoing projects at Prime Medicine in engineering proteins for cell-based therapeutics, and his thoughts on the current challenges and future developments in gene editing and precision medicine.
Links from this episode:
Prime Medicine
PEGS Boston Conference & Expo
By Cambridge Healthtech Institute4.8
2525 ratings
Dr. Andrew Anzalone, head of the Prime Editing Platform and scientific co-founder at Prime Medicine, is the winner of the PEGS Boston 2023 Young Scientist Keynote. He was invited to sit down with Brandon DeKosky, assistant professor of chemical engineering at MIT, to discuss prime editing and its precision in treating inherited genetic mutations. Anzalone outlines the next generation tool’s advantages over traditional CRISPR methods and the mechanism creating fewer gene editing errors. He also discusses his clinical training and background, the ongoing projects at Prime Medicine in engineering proteins for cell-based therapeutics, and his thoughts on the current challenges and future developments in gene editing and precision medicine.
Links from this episode:
Prime Medicine
PEGS Boston Conference & Expo

43,831 Listeners

32,011 Listeners

30,711 Listeners

1,834 Listeners

112,426 Listeners

125 Listeners

9,530 Listeners

320 Listeners

6,094 Listeners

6,444 Listeners

6,394 Listeners

34 Listeners

5,520 Listeners

18 Listeners

13 Listeners